US Patent Family Members and Approved Drugs for Australia Patent: 2375392
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: AU2375392
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,462,535 | 2044-05-16 | insulin human | Novo Nordisk Inc. | NOVOLIN R |
| 5,462,535 | 2044-05-16 | insulin isophane human and insulin human | Novo Nordisk Inc. | NOVOLIN 70/30 |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
